Tonix Pharmaceuticals Holding Corp. (TNXP) Operating cash flow 2016–2025
Tonix Pharmaceuticals Holding Corp. (TNXP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$99.8MFY2025 · since FY2016: -$37.3M → -$99.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$99.8M | -63.9% |
| FY2024 | -$60.9M | +40.3% |
| FY2023 | -$102.0M | -4.0% |
| FY2022 | -$98.1M | -29.8% |
| FY2021 | -$75.6M | -55.6% |
| FY2020 | -$48.6M | -82.0% |
| FY2019 | -$26.7M | -11.3% |
| FY2018 | -$24.0M | -25.3% |
| FY2017 | -$19.1M | +48.7% |
| FY2016 | -$37.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice